Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
PRME

Prime Medicine, Inc. (PRME)

NASDAQ
$3.84
+$0.02
(+0.66%)
Previous Close: ⁦$3.84⁩
Market Closed

Last updated: ⁦2026-11-19 02:28:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Prime Medicine, Inc. (PRME) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $3.84, with a market capitalization of $934.34M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.67 to $5.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$934.34M

$3.81

$4.28

$3.79

$3.84

3.70M

4.60M

--

$5.91

$2.67

--

2026-09-30

Prime Medicine, Inc. (PRME) Latest Closing Stock Price

Prime Medicine, Inc. (PRME) last closed at $3.84 as of 2026-11-19 00:47:00, up 0.66% ($0.02) from the previous close of $3.84.

During the latest regular trading session, PRME traded between $3.79 and $4.28, with a volume of 3.70M shares. The closing price was near the lower end and near the middle of its 52-week range.

Prime Medicine, Inc. (PRME) 7-Day Stock Price Change

Over the past seven days, Prime Medicine, Inc. (PRME) moved from $4.30 to $3.84, representing a decline of 10.81% ($0.46).

The stock traded between $3.73 and $4.71 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 6.46 million shares, up versus the previous seven-day period, indicating higher trading activity.

PRME 52-Week Price Position

Position in Range: 36.0%

52W Low$2.67
52W High$5.91

PRME is currently trading at $3.84, placing it 36.0% of the way from its 52-week low of $2.67 to its 52-week high of $5.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Prime Medicine, Inc. (PRME)?

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

Prime Medicine, Inc. Information

Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
146
Exchange
NASDAQ
Company Website

PRME Stock Events

View the latest dividend and stock split events for Prime Medicine, Inc.

Dividend
Ex-Dividend DateSep 10, 2019
Payment DateSep 12, 2019
Dividend Per Share$0.8

PRME News

Latest news related to Prime Medicine, Inc. and PRME stock.

  • Benzinga

    HC Wainwright & Co. Reiterates Buy on Prime Medicine, Maintains $8 Price Target

    HC Wainwright & Co. analyst Arthur He reiterates Prime Medicine (NASDAQ:PRME) with a Buy and maintains $8 price target.

    Read Full Article
  • Benzinga

    Prime Medicine Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $4.213M Beat $1.206M Estimate

    Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is a 31.25 percent increase over losses of $(0.32) per share from the

    Read Full Article
  • Benzinga

    Prime Medicine Closes Underwritten Public Offering Of 41,071,428 Common Shares For Gross Proceeds Of ~$143.7M

    Read Full Article
  • Massive

    Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

    Prime Medicine (PRME) reported a quarterly loss of $0.22 per share, beating consensus estimates of $0.23 loss by 4.35%, but missed revenue expectations with $4.21 million versus the consensus estimate, down 25.8%. The stock has outperformed the S&P 500 by 12.6% year-to-date but carries a Zacks Rank #3 (Hold) rating with mixed estimate revisions.

    Read Full Article
  • Massive

    Absci Corporation (ABSI) Reports Q3 Loss, Misses Revenue Estimates

    Absci Corporation (ABSI) reported a quarterly loss of $0.17 per share, missing the consensus estimate of $0.15 loss by 13.33%. Revenue came in at $0.3 million, significantly missing estimates by 88.43%. The company has failed to beat consensus estimates for four consecutive quarters. Despite a 190% year-to-date gain, ABSI received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.

    Read Full Article

Ways to Trade PRME at MEXC

PRME MEXC RealStocks

Own real PRME shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Prime Medicine, Inc. (PRME) Stock on MEXC

Eligible investors can buy real shares of Prime Medicine, Inc. (PRME) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for PRME and Place Your Order
Step 3: Search for PRME and Place Your Order
Open the RealStocks trading page and search for PRME. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Prime Medicine, Inc. (PRME) stock price today?
Prime Medicine, Inc. (PRME) is currently trading at $3.84, up 0.66% ($0.02) from the previous close of $3.84. Intraday prices update in real time during regular trading hours.
2.Is PRME stock going up or down today?
As of 2026-11-19 00:47:00, PRME is trading at $3.84, up 0.66% ($0.02) from its previous close of $3.84. The stock has traded between $3.79 and $4.28 during today’s regular session. Past price movements do not guarantee future results.
3.What is PRME pre-market price?
As of 2026-11-19 00:47:00, PRME is trading at $3.88 in pre-market trading, up 0.91% ($0.04) from the previous close of $3.84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is PRME after-hours price?
As of 2026-11-19 00:47:00, PRME is trading at $3.87 in after-hours trading, up 0.99% ($0.04) from the regular-session close of $3.84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is PRME stock trading now?
PRME trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does PRME sit relative to its 52-week high and low?
Over the past 52 weeks, PRME has traded between a low of $2.67 and a high of $5.91. At $3.84, the stock is positioned 36.0% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Prime Medicine, Inc. in?
Prime Medicine, Inc. (PRME) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Prime Medicine, Inc.'s market capitalization and where is it listed?
Prime Medicine, Inc. is listed on the NASDAQ exchange with a market capitalization of $934.34M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is PRME valued in terms of P/E ratio and EPS?
PRME trades at a P/E ratio of --, based on trailing-twelve-month EPS of $-0.79. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Prime Medicine, Inc. pay a dividend?
Prime Medicine, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Prime Medicine, Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PRME, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

PRME Stock Calculator

Estimate the value between PRME shares and USD.

PRME Shares to USD

PRME Shares
PRME
PRME
USD
USD
USD

1.00 PRME shares = 3.835 USD

Calculations are estimates based on the latest available price and are for reference only.